New research reveals that individuals over 40 with type 2 diabetes taking statins may have a reduced risk of kidney disease. The study spans 21 years with 20,000...
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
41 readers recommended
Novo Nordisk's REDEFINE trials test CagriSema for weight and heart health in adults with type 2 diabetes and/or obesity. Participate and shape diabetes care.
61 readers recommended
Busy healthcare providers may not always be able to listen to their patients' needs. Here's what to look for in a healthcare team and how to advocate for your mental...
48 readers recommended
Uncover the complex link between obesity, asthma, and diabetes, plus effective management strategies to deal with allergens during peak allergy season.
92 readers recommended
Explore the crucial role sleep plays in diabetes management. Understand the impact of sleep deprivation on glucose levels, dietary habits, and overall wellbeing.
60 readers recommended
Discover how a new predictive tool can forecast the risk of chronic kidney disease in type 2 diabetes patients. Learn about its benefits, limitations, and potential for...
42 readers recommended
Getting quality sleep is challenging for children with type 1 diabetes, who deal with sleep disturbances like device alarms, low episodes, and more. Here we share sleep-...
129 readers recommended
Lifestyle changes like diet and exercise are key to the prevention and management of diabetes-related complications like foot disease. Here’s why it’s important to be...
42 readers recommended
Research shows screening children ages 2-6 best predicts childhood type 1 diabetes. Early screening also leads to more timely treatment, better outcomes, and reduced...
40 readers recommended
Obesity management options include lifestyle changes, medication, and surgery. Here's what you need to know to make informed decisions about what treatments are optimal...
58 readers recommended
Discover how cold exposure therapy might boost insulin sensitivity and lower blood sugar in people with diabetes. Scientific evidence is still unfolding.
61 readers recommended
Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.
58 readers recommended
Pfizer propels clinical trials for danuglipron, a novel oral GLP-1 medication for obesity and type 2 diabetes, with promising preliminary results for A1C and weight loss.
49 readers recommended
Explore the role of artificial intelligence in diabetic retinopathy detection with Eyenuk's innovative technology. Here we also examine the disputed effects of GLP-1s on...
44 readers recommended
New research reveals a higher dementia risk in early-onset diabetes. Preventing prediabetes progression may be key to mitigating this risk.
60 readers recommended
At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...
63 readers recommended
A lot has happened this year advancing time in range as a primary glucose metric in diabetes care globally. Though we aren’t there yet, a panel shared their thoughts on...
159 readers recommended
Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...
135 readers recommended
PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.
67 readers recommended
Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.